{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T06:14:45Z","timestamp":1768457685707,"version":"3.49.0"},"reference-count":28,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2022.11268","type":"journal-article","created":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T06:03:58Z","timestamp":1647842638000},"source":"Crossref","is-referenced-by-count":4,"title":["Favorable outcomes of patients with sickle cell disease hospitalized due to COVID\u201119: A report of three cases"],"prefix":"10.3892","volume":"23","author":[{"given":"Anastasios","family":"Tentolouris","sequence":"first","affiliation":[{"name":"First Department of Propedeutic and Internal Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos","family":"Stafylidis","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, Laiko General Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos","family":"Siafarikas","sequence":"additional","affiliation":[{"name":"First Department of Propedeutic and Internal Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Dimopoulou","sequence":"additional","affiliation":[{"name":"Hem\u03bfglobinopathies Reference Center, Laiko General Hospital, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sotiria","family":"Makrodimitri","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases\u2011COVID\u201119 Unit, Laiko General Hospital, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stelios","family":"Bousi","sequence":"additional","affiliation":[{"name":"Renal Transplantation Unit, Laiko General Hospital, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petros","family":"Papalexis","sequence":"additional","affiliation":[{"name":"Unit of Endocrinology, First Department of Internal Medicine, Laiko General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos","family":"Damaskos","sequence":"additional","affiliation":[{"name":"Renal Transplantation Unit, Laiko General Hospital, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Trakas","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Sismanogleio Hospital, 15126 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pagona","family":"Sklapani","sequence":"additional","affiliation":[{"name":"Department of Cytology, Mitera Hospital, 15123 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Demetrios","family":"Spandidos","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Virology, School of Medicine, University of Crete, 71003 Heraklion, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasiliki","family":"Georgakopoulou","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases\u2011COVID\u201119 Unit"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2022,3,21]]},"reference":[{"key":"key20220428103036_b1-ETM-23-5-11268","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/pbc.24175","article-title":"A global perspective on sickle cell disease","volume":"59","author":"Aygun","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"key20220428103036_b2-ETM-23-5-11268","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0140-6736(17)30193-9","article-title":"Sickle cell disease","volume":"390","author":"Ware","year":"2017","journal-title":"Lancet"},{"key":"key20220428103036_b3-ETM-23-5-11268","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.3324\/haematol.2019.239350","article-title":"The molecular basis for the prothrombotic state in sickle cell disease","volume":"105","author":"Shet","year":"2020","journal-title":"Haematologica"},{"key":"key20220428103036_b4-ETM-23-5-11268","first-page":"1","article-title":"Evidence-based management of sickle cell disease in the emergency department","volume":"13","author":"Glassberg","year":"2011","journal-title":"Emerg Med Pract"},{"key":"key20220428103036_b5-ETM-23-5-11268","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1600-0609.2011.01647.x","article-title":"Acute chest syndrome: Sickle cell disease","volume":"87","author":"Paul","year":"2011","journal-title":"Eur J Haematol"},{"key":"key20220428103036_b6-ETM-23-5-11268","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1056\/NEJM200006223422502","article-title":"Causes and outcomes of the acute chest syndrome in sickle cell disease. National acute chest syndrome study group","volume":"342","author":"Vichinsky","year":"2000","journal-title":"N Engl J Med"},{"key":"key20220428103036_b7-ETM-23-5-11268","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1111\/bjh.16779","article-title":"COVID-19 infection and sickle cell disease: A UK centre experience","volume":"190","author":"McCloskey","year":"2020","journal-title":"Br J Haematol"},{"key":"key20220428103036_b8-ETM-23-5-11268","doi-asserted-by":"publisher","first-page":"E154","DOI":"10.1002\/ajh.25809","article-title":"COVID-19 pneumonia as a cause of acute chest syndrome in an adult sickle cell patient","volume":"95","author":"Beerkens","year":"2020","journal-title":"Am J Hematol"},{"issue":"104362","key":"key20220428103036_b9-ETM-23-5-11268","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2020.104362","article-title":"Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past","volume":"127","author":"Giannis","year":"2020","journal-title":"J Clin Virol"},{"key":"key20220428103036_b10-ETM-23-5-11268","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"key":"key20220428103036_b11-ETM-23-5-11268","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1016\/S0049-3848(09)70136-7","article-title":"Effects of race and ethnicity on the incidence of venous thromboembolism","volume":"123 (Suppl 4)","author":"White","year":"2009","journal-title":"Thromb Res"},{"issue":"46","key":"key20220428103036_b12-ETM-23-5-11268","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-021-01412-x","article-title":"Severe COVID-19 with acute respiratory distress syndrome (ARDS) in a sickle cell disease adult patient: Case report","volume":"21","author":"Teulier","year":"2021","journal-title":"BMC Pulm Med"},{"key":"key20220428103036_b13-ETM-23-5-11268","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000519028","article-title":"COVID-19 infection in sickle cell patients in a developing Country: A case series","volume":"145","author":"Silva-Pinto","year":"2022","journal-title":"Acta Haematol"},{"key":"key20220428103036_b14-ETM-23-5-11268","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1111\/bjh.16734","article-title":"COVID-19 infection in patients with sickle cell disease","volume":"189","author":"Hussain","year":"2020","journal-title":"Br J Haematol"},{"key":"key20220428103036_b15-ETM-23-5-11268","doi-asserted-by":"publisher","first-page":"e632","DOI":"10.1016\/S2352-3026(20)30204-0","article-title":"Prognosis of patients with sickle cell disease and COVID-19: A French experience","volume":"7","author":"Arlet","year":"2020","journal-title":"Lancet Haematol"},{"key":"key20220428103036_b16-ETM-23-5-11268","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1080\/03630269.2020.1797775","article-title":"Impact of COVID-19 infection on 24 patients with sickle cell disease. One center urban experience, Detroit, MI, USA","volume":"44","author":"Balanchivadze","year":"2020","journal-title":"Hemoglobin"},{"issue":"e931758","key":"key20220428103036_b17-ETM-23-5-11268","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.931758","article-title":"COVID-19 presentation in patients with sickle cell disease: A case series","volume":"22","author":"Chen-Goodspeed","year":"2021","journal-title":"Am J Case Rep"},{"key":"key20220428103036_b18-ETM-23-5-11268","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.3324\/haematol.2020.259440","article-title":"Real-time national survey of COVID-19 in hemoglobinopathy and rare inherited anemia patients","volume":"105","author":"Telfer","year":"2020","journal-title":"Haematologica"},{"key":"key20220428103036_b19-ETM-23-5-11268","doi-asserted-by":"publisher","first-page":"E86","DOI":"10.1002\/ajh.26432","article-title":"Risk factors for severe COVID-19 in hospitalized sickle cell disease patients: A study of 319 patients in France","volume":"97","author":"Arlet","year":"2022","journal-title":"Am J Hematol"},{"key":"key20220428103036_b20-ETM-23-5-11268","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.3201\/eid2610.202792","article-title":"Coronavirus disease among persons with sickle cell disease, United States, March 20-May 21, 2020","volume":"26","author":"Panepinto","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"key20220428103036_b21-ETM-23-5-11268","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1182\/bloodadvances.2020003456","article-title":"Clinical predictors of poor outcomes in patients with sickle cell disease and COVID-19 infection","volume":"5","author":"Minniti","year":"2021","journal-title":"Blood Adv"},{"key":"key20220428103036_b22-ETM-23-5-11268","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1182\/bloodadvances.2020003741","article-title":"COVID-19 in individuals with sickle cell disease\/trait compared with other Black individuals","volume":"5","author":"Singh","year":"2021","journal-title":"Blood Adv"},{"key":"key20220428103036_b23-ETM-23-5-11268","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.7326\/M21-1375","article-title":"Sickle cell disorders and severe COVID-19 outcomes: A cohort study","volume":"174","author":"Clift","year":"2021","journal-title":"Ann Intern Med"},{"key":"key20220428103036_b24-ETM-23-5-11268","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1182\/bloodadvances.2021004288","article-title":"Comorbidities are risk factors for hospitalization and serious COVID-19 illness in children and adults with sickle cell disease","volume":"5","author":"Mucalo","year":"2021","journal-title":"Blood Adv"},{"key":"key20220428103036_b25-ETM-23-5-11268","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.3324\/haematol.2020.255398","article-title":"COVID-19 and sickle cell disease","volume":"105","author":"Menapace","year":"2020","journal-title":"Haematologica"},{"key":"key20220428103036_b26-ETM-23-5-11268","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.15585\/mmwr.mm7034e5","article-title":"SARS-CoV-2 infections and hospitalizations among persons aged \u226516 Years, by vaccination status-los angeles county, California, May 1-July 25, 2021","volume":"70","author":"Griffin","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"e21026","key":"key20220428103036_b27-ETM-23-5-11268","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.21026","article-title":"COVID-19 vaccine perception and hesitancy among patients with sickle cell disease in the western region of Saudi Arabia","volume":"14","author":"Jan","year":"2022","journal-title":"Cureus"},{"key":"key20220428103036_b28-ETM-23-5-11268","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1093\/glycob\/cwn093","article-title":"Inhibition of the interaction between the SARS-CoV spike protein and its cellular receptor by anti-histo-blood group antibodies","volume":"18","author":"Guillon","year":"2008","journal-title":"Glycobiology"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T07:30:46Z","timestamp":1651131046000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2022.11268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,21]]},"references-count":28,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,3,21]]}},"URL":"https:\/\/doi.org\/10.3892\/etm.2022.11268","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,21]]},"article-number":"338"}}